ONC BeOne Medicines Ltd.
Nasdaq · SEC CIK 1651308 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $361.20M 49 sales by 12 insiders
- Filings on record
- 271 since 2021-07-01, latest 2026-09-10 16:49
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| OYLER JOHN | CEO, Dir | — | $327.88M |
| Wang Xiaodong | Dir, COB, Scientific Advisory Brd | — | $13.37M |
| Wu Xiaobin | Pres, COO | — | $8.75M |
| Lee Chan Henry | SVP, GC | — | $7.95M |
| Wang Lai | Pres, Gbl Head of R, D | — | $1.17M |
| Sanders Corazon (Corsee) D. | Dir | — | $961.2K |
| Rosenberg Aaron | CFO | — | $524.4K |
| BAKER BROS. ADVISORS LP | Dir | — | $262.0K |
| Ball Titus B. | Principal Accounting Off | — | $127.3K |
| Dugan Margaret | Dir | — | $65.6K |
Transactions 336
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-10 16:49 | 2026-09-08 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale+OE | $349.10 | -38.3K | 0 | -100% | -$13.37M |
| DT | 2026-09-10 16:49 | 2026-09-08 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | M - OptEx | $36.90 | +31.0K | 31.0K | New | +$1.14M |
| 2026-09-03 17:17 | 2026-09-01 | ONC | Ball Titus B. | Principal Accounting Off | S - Sale | $355.86 | -132 | 0 | -100% | -$47.0K | |
| T | 2026-08-27 17:12 | 2026-08-25 | ONC | Wu Xiaobin | Pres, COO | S - Sale | $380.00 | -280 | 0 | -100% | -$106.4K |
| DMT | 2026-08-13 20:54 | 2026-08-11 | ONC | Lee Chan Henry | SVP, GC | M - OptEx | $191.37 | +2,666 | 2,666 | New | +$510.2K |
| DT | 2026-08-13 20:54 | 2026-08-11 | ONC | Lee Chan Henry | SVP, GC | S - Sale+OE | $360.00 | -2,666 | 0 | -100% | -$959.8K |
| MT | 2026-08-12 17:53 | 2026-08-10+ | ONC | OYLER JOHN | CEO, Dir | S - Sale | $359.12 | -240.8K | 0 | -100% | -$86.48M |
| 2026-08-05 17:15 | 2026-08-03 | ONC | Rosenberg Aaron | CFO | S - Sale | $312.71 | -1,157 | 0 | -100% | -$361.8K | |
| 2026-08-03 17:18 | 2026-07-30 | ONC | Lee Chan Henry | SVP, GC | S - Sale | $323.69 | -1,044 | 0 | -100% | -$337.9K | |
| DMT | 2026-07-24 16:51 | 2026-07-22 | ONC | Lee Chan Henry | SVP, GC | M - OptEx | $191.58 | +1,669 | 1,669 | New | +$319.7K |
| DT | 2026-07-24 16:51 | 2026-07-22 | ONC | Lee Chan Henry | SVP, GC | S - Sale+OE | $325.00 | -1,669 | 0 | -100% | -$542.4K |
| DMT | 2026-07-22 17:03 | 2026-07-20+ | ONC | OYLER JOHN | CEO, Dir | S - Sale+OE | $315.28 | -109.7K | 0 | -100% | -$34.59M |
| DT | 2026-07-22 17:03 | 2026-07-20 | ONC | OYLER JOHN | CEO, Dir | M - OptEx | $119.96 | +34.0K | 34.0K | New | +$4.08M |
| DT | 2026-07-17 17:36 | 2026-07-17 | ONC | OYLER JOHN | CEO, Dir | M - OptEx | $119.96 | +64.6K | 64.6K | New | +$7.75M |
| DMT | 2026-07-17 17:36 | 2026-07-17 | ONC | OYLER JOHN | CEO, Dir | S - Sale+OE | $312.00 | -64.6K | 0 | -100% | -$20.16M |
| DMT | 2026-07-17 17:31 | 2026-07-15+ | ONC | OYLER JOHN | CEO, Dir | M - OptEx | $145.28 | +283.2K | 166.6K | New | +$41.14M |
| DMT | 2026-07-17 17:31 | 2026-07-15+ | ONC | OYLER JOHN | CEO, Dir | S - Sale+OE | $315.56 | -283.2K | 0 | -100% | -$89.35M |
| DMT | 2026-07-14 21:26 | 2026-07-14 | ONC | OYLER JOHN | CEO, Dir | S - Sale+OE | $305.95 | -145.9K | 0 | -100% | -$44.63M |
| DMT | 2026-07-14 21:26 | 2026-07-14 | ONC | OYLER JOHN | CEO, Dir | M - OptEx | $54.06 | +133.6K | 133.6K | New | +$7.22M |
| DMT | 2026-07-14 21:25 | 2026-07-10+ | ONC | OYLER JOHN | CEO, Dir | M - OptEx | $36.90 | +60.2K | 48.5K | New | +$2.22M |
| DMT | 2026-07-14 21:25 | 2026-07-10+ | ONC | OYLER JOHN | CEO, Dir | S - Sale+OE | $303.18 | -60.2K | 0 | -100% | -$18.26M |
| DMT | 2026-07-10 16:44 | 2026-07-08 | ONC | Lee Chan Henry | SVP, GC | M - OptEx | $191.56 | +664 | 664 | New | +$127.2K |
| DT | 2026-07-10 16:44 | 2026-07-08 | ONC | Lee Chan Henry | SVP, GC | S - Sale+OE | $302.46 | -664 | 0 | -100% | -$200.8K |
| 2026-06-25 17:15 | 2026-06-23 | ONC | Wu Xiaobin | Pres, COO | S - Sale | $276.26 | -1,292 | 0 | -100% | -$356.9K | |
| M | 2026-06-25 17:15 | 2026-06-23 | ONC | OYLER JOHN | CEO, Dir | S - Sale | $273.78 | -3,410 | 0 | -100% | -$933.6K |
| 2026-06-25 17:14 | 2026-06-23 | ONC | Wang Lai | Pres, Gbl Head of R, D | S - Sale | $276.74 | -1,068 | 0 | -100% | -$295.6K | |
| 2026-06-18 17:19 | 2026-06-16 | ONC | Wu Xiaobin | Pres, COO | S - Sale | $266.76 | -1,357 | 0 | -100% | -$362.0K | |
| M | 2026-06-18 17:19 | 2026-06-16 | ONC | OYLER JOHN | CEO, Dir | S - Sale | $265.55 | -3,693 | 0 | -100% | -$980.7K |
| 2026-06-18 17:19 | 2026-06-16 | ONC | Lee Chan Henry | SVP, GC | S - Sale | $265.98 | -590 | 0 | -100% | -$156.9K | |
| 2026-06-18 17:19 | 2026-06-16 | ONC | Wang Lai | Pres, Gbl Head of R, D | S - Sale | $265.39 | -1,169 | 0 | -100% | -$310.2K | |
| 2026-06-15 17:55 | 2026-06-11 | ONC | Ball Titus B. | Principal Accounting Off | A - Grant | $0.00 | +31.2K | 99.6K | +46% | $0 | |
| M | 2026-06-15 17:55 | 2026-06-11 | ONC | Ball Titus B. | Principal Accounting Off | S - Sale | $257.20 | -169 | 0 | -100% | -$43.5K |
| D | 2026-06-15 17:55 | 2026-06-11 | ONC | Wang Lai | Pres, Gbl Head of R, D | A - Grant | $0.00 | +118.6K | 1.71M | +7% | $0 |
| D | 2026-06-15 17:55 | 2026-06-11 | ONC | Wang Lai | Pres, Gbl Head of R, D | S - Sale | $261.00 | -756 | 0 | -100% | -$197.3K |
| D | 2026-06-15 17:55 | 2026-06-11 | ONC | Rosenberg Aaron | CFO | A - Grant | $0.00 | +71.2K | 397.9K | +22% | $0 |
| D | 2026-06-15 17:55 | 2026-06-11 | ONC | Rosenberg Aaron | CFO | S - Sale | $257.74 | -631 | 0 | -100% | -$162.6K |
| D | 2026-06-15 17:55 | 2026-06-11 | ONC | Wu Xiaobin | Pres, COO | A - Grant | $0.00 | +118.6K | 1.31M | +10% | $0 |
| D | 2026-06-15 17:55 | 2026-06-11 | ONC | Wu Xiaobin | Pres, COO | S - Sale | $261.20 | -626 | 0 | -100% | -$163.5K |
| D | 2026-06-15 17:55 | 2026-06-11 | ONC | Lee Chan Henry | SVP, GC | A - Grant | $0.00 | +45.1K | 346.6K | +15% | $0 |
| D | 2026-06-15 17:55 | 2026-06-11 | ONC | Lee Chan Henry | SVP, GC | S - Sale | $257.63 | -428 | 0 | -100% | -$110.3K |
| D | 2026-06-15 17:55 | 2026-06-11 | ONC | OYLER JOHN | CEO, Dir | A - Grant | $0.00 | +177.9K | 5.70M | +3% | $0 |
| DM | 2026-06-15 17:55 | 2026-06-11 | ONC | OYLER JOHN | CEO, Dir | S - Sale | $257.24 | -1,949 | 0 | -100% | -$501.4K |
| D | 2026-06-15 17:54 | 2026-06-11 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | A - Grant | $0.00 | +99.9K | 4.68M | +2% | $0 |
| 2026-06-15 17:51 | 2026-06-11 | ONC | BRANDICOURT OLIVIER | Dir | A - Grant | $0.00 | +19.0K | 46.3K | +69% | $0 | |
| 2026-06-15 17:50 | 2026-06-11 | ONC | HOOPER ANTHONY C | Dir | A - Grant | $0.00 | +19.0K | 83.7K | +29% | $0 | |
| 2026-06-15 17:50 | 2026-06-11 | ONC | Mooney Elizabeth Fisher | Dir | A - Grant | $0.00 | +19.0K | 19.0K | New | $0 | |
| 2026-06-15 17:50 | 2026-06-11 | ONC | Dugan Margaret | Dir | A - Grant | $0.00 | +19.0K | 73.2K | +35% | $0 | |
| 2026-06-15 17:49 | 2026-06-11 | ONC | Sawyers Charles Lazelle | Dir | A - Grant | $0.00 | +19.0K | 19.0K | +474,500% | $0 | |
| 2026-06-15 17:49 | 2026-06-11 | ONC | Sharp Shalini | Dir | A - Grant | $0.00 | +19.0K | 38.1K | +99% | $0 | |
| 2026-06-15 17:49 | 2026-06-11 | ONC | Riva Alessandro | Dir | A - Grant | $0.00 | +19.0K | 73.2K | +35% | $0 | |
| MI | 2026-06-15 16:38 | 2026-06-11 | ONC | BAKER BROS. ADVISORS LP | Dir | A - Grant | $0.00 | +38.0K | 161.6K | +31% | $0 |
| M | 2026-06-10 17:27 | 2026-06-08 | ONC | Ball Titus B. | Principal Accounting Off | S - Sale | $271.33 | -136 | 0 | -100% | -$36.9K |
| M | 2026-06-10 17:26 | 2026-06-08 | ONC | Lee Chan Henry | SVP, GC | S - Sale | $270.42 | -871 | 0 | -100% | -$235.5K |
| M | 2026-06-10 17:25 | 2026-06-08 | ONC | Wang Lai | Pres, Gbl Head of R, D | S - Sale | $269.38 | -1,367 | 0 | -100% | -$368.2K |
| M | 2026-06-10 17:23 | 2026-06-08 | ONC | Wu Xiaobin | Pres, COO | S - Sale | $269.37 | -1,484 | 0 | -100% | -$399.7K |
| M | 2026-06-10 17:22 | 2026-06-08 | ONC | OYLER JOHN | CEO, Dir | S - Sale | $270.56 | -4,940 | 0 | -100% | -$1.34M |
| 2026-06-03 16:10 | 2026-06-01 | ONC | Yi Qingqing | Dir | S - Sale | $279.13 | -235 | 0 | -100% | -$65.6K | |
| 2026-05-27 17:29 | 2026-05-22 | ONC | Riva Alessandro | Dir | S - Sale | $309.51 | -212 | 0 | -100% | -$65.6K | |
| 2026-05-27 17:26 | 2026-05-22 | ONC | Dugan Margaret | Dir | S - Sale | $309.60 | -212 | 0 | -100% | -$65.6K | |
| 2026-05-27 17:26 | 2026-05-22 | ONC | Sanders Corazon (Corsee) D. | Dir | S - Sale | $309.59 | -212 | 0 | -100% | -$65.6K | |
| MI | 2026-05-27 16:54 | 2026-05-22 | ONC | BAKER BROS. ADVISORS LP | Dir | S - Sale | $23.82 | -11.0K | 142.6K | -7% | -$262.0K |
| DMT | 2026-05-15 16:39 | 2026-05-13 | ONC | Lee Chan Henry | SVP, GC | M - OptEx | $191.56 | +332 | 332 | New | +$63.6K |
| DT | 2026-05-15 16:39 | 2026-05-13 | ONC | Lee Chan Henry | SVP, GC | S - Sale+OE | $310.72 | -332 | 0 | -100% | -$103.2K |
| DMT | 2026-04-10 17:40 | 2026-04-08 | ONC | Lee Chan Henry | SVP, GC | M - OptEx | $191.56 | +332 | 332 | New | +$63.6K |
| DT | 2026-04-10 17:40 | 2026-04-08 | ONC | Lee Chan Henry | SVP, GC | S - Sale+OE | $311.59 | -332 | 0 | -100% | -$103.4K |
| DM | 2026-03-13 | 2026-03-11 | ONC | Lee Chan Henry | SVP, GC | M - OptEx | $191.64 | +341 | 341 | New | +$65.3K |
| D | 2026-03-13 | 2026-03-11 | ONC | Lee Chan Henry | SVP, GC | S - Sale+OE | $300.00 | -341 | 0 | -100% | -$102.3K |
| M | 2026-03-10 | 2026-03-06 | ONC | OYLER JOHN | CEO, Dir | A - Grant | $0.00 | +444.9K | 5.49M | +9% | $0 |
| M | 2026-03-10 | 2026-03-06 | ONC | Lee Chan Henry | SVP, GC | A - Grant | $0.00 | +95.3K | 318.4K | +43% | $0 |
| M | 2026-03-10 | 2026-03-06 | ONC | Rosenberg Aaron | CFO | A - Grant | $0.00 | +119.6K | 334.9K | +56% | $0 |
| M | 2026-03-10 | 2026-03-06 | ONC | Wang Lai | Pres, Gbl Head of R, D | A - Grant | $0.00 | +167.6K | 1.62M | +12% | $0 |
| M | 2026-03-10 | 2026-03-06 | ONC | Wu Xiaobin | Pres, COO | A - Grant | $0.00 | +247.5K | 1.22M | +26% | $0 |
| DM | 2026-02-06 | 2026-02-04 | ONC | Lee Chan Henry | SVP, GC | M - OptEx | $191.40 | +1,660 | 1,660 | New | +$317.7K |
| DM | 2026-02-06 | 2026-02-04 | ONC | Lee Chan Henry | SVP, GC | S - Sale+OE | $349.52 | -1,660 | 996 | -62% | -$580.2K |
| DM | 2026-01-09 | 2026-01-07 | ONC | Lee Chan Henry | SVP, GC | M - OptEx | $191.56 | +664 | 664 | New | +$127.2K |
| D | 2026-01-09 | 2026-01-07 | ONC | Lee Chan Henry | SVP, GC | S - Sale+OE | $331.76 | -664 | 0 | -100% | -$220.3K |
| 2026-01-05 | 2025-12-31 | ONC | Wang Lai | Pres, Gbl Head of R, D | A - Grant | $0.00 | +427.9K | 1.45M | +42% | $0 | |
| M | 2025-12-17 | 2025-12-15+ | ONC | OYLER JOHN | CEO, Dir | S - Sale | $306.59 | -100.0K | 84.1K | -54% | -$30.66M |
| DM | 2025-12-12 | 2025-12-10+ | ONC | Lee Chan Henry | SVP, GC | M - OptEx | $191.56 | +664 | 332 | New | +$127.2K |
| DM | 2025-12-12 | 2025-12-10+ | ONC | Lee Chan Henry | SVP, GC | S - Sale+OE | $321.64 | -664 | 0 | -100% | -$213.6K |
| D | 2025-12-01 | 2025-11-26 | ONC | Sanders Corazon (Corsee) D. | Dir | M - OptEx | $159.03 | +2,627 | 2,627 | New | +$417.8K |
| DM | 2025-12-01 | 2025-11-26 | ONC | Sanders Corazon (Corsee) D. | Dir | S - Sale+OE | $340.89 | -2,627 | 804 | -77% | -$895.5K |
| M | 2025-11-19 | 2025-11-17 | ONC | Wu Xiaobin | Pres, COO | S - Sale | $380.43 | -3,991 | 836 | -83% | -$1.52M |
| M | 2025-11-14 | 2025-11-12+ | ONC | Wu Xiaobin | Pres, COO | S - Sale | $365.22 | -16.0K | 1,769 | -90% | -$5.85M |
| DM | 2025-11-14 | 2025-11-12 | ONC | Lee Chan Henry | SVP, GC | S - Sale+OE | $349.17 | -996 | 0 | -100% | -$347.8K |
| DM | 2025-11-14 | 2025-11-12 | ONC | Lee Chan Henry | SVP, GC | M - OptEx | $191.47 | +996 | 996 | New | +$190.7K |
| M | 2025-11-13 | 2025-11-11+ | ONC | OYLER JOHN | CEO, Dir | G - Gift | $0.00 | -1.01M | 7.30M | -12% | $0 |
| 2025-11-12 | 2025-11-07 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | G - Gift | $0.00 | -424.1K | 4.58M | -8% | $0 | |
| DM | 2025-10-10 | 2025-10-08 | ONC | Lee Chan Henry | SVP, GC | S - Sale+OE | $350.40 | -10.7K | 4,162 | -72% | -$3.74M |
| DM | 2025-10-10 | 2025-10-08 | ONC | Lee Chan Henry | SVP, GC | M - OptEx | $211.04 | +9,559 | 9,559 | New | +$2.02M |
| M | 2025-09-18 | 2025-09-16 | ONC | OYLER JOHN | CEO, Dir | S - Sale | $325.71 | -27.8K | 4,408 | -86% | -$9.06M |
| DM | 2025-09-12 | 2025-09-10 | ONC | Lee Chan Henry | SVP, GC | M - OptEx | $197.10 | +8,894 | 8,598 | New | +$1.75M |
| DM | 2025-09-12 | 2025-09-10 | ONC | Lee Chan Henry | SVP, GC | S - Sale+OE | $325.53 | -10.0K | 500 | -95% | -$3.26M |
| 2025-09-11 | 2025-09-09 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | G - Gift | $0.00 | -148.1K | 5.01M | -3% | $0 | |
| I | 2025-09-11 | 2025-09-09 | ONC | Wang Lai | Gbl Head of R, D | S - Sale | $350.06 | -5,000 | 0 | -100% | -$1.75M |
| D | 2025-09-09 | 2025-09-05 | ONC | Sanders Corazon (Corsee) D. | Dir | S - Sale+OE | $337.00 | -2,665 | 0 | -100% | -$898.1K |
| D | 2025-09-09 | 2025-09-05 | ONC | Sanders Corazon (Corsee) D. | Dir | M - OptEx | $155.68 | +2,665 | 2,665 | New | +$414.9K |
| 2025-09-04 | 2025-09-02 | ONC | Ball Titus B. | Principal Accounting Off | S - Sale | $326.76 | -122 | 0 | -100% | -$39.9K | |
| DM | 2025-08-15 | 2025-08-13 | ONC | Lee Chan Henry | SVP, GC | M - OptEx | $177.90 | +8,230 | 8,230 | New | +$1.46M |
| DM | 2025-08-15 | 2025-08-13 | ONC | Lee Chan Henry | SVP, GC | S - Sale+OE | $300.45 | -11.0K | 0 | -100% | -$3.31M |
Purchase Sale Sale after option exercise All abbreviations